Results 1 to 10 of about 74,627 (275)
Management of malignant pleural effusions [PDF]
Thorax, 2000 Malignant pleural effusion is a common problem in respiratory medicine and oncology and in some series accounts for up to 50% of all pleural effusions.1 2 The median survival following diagnosis ranges from three to 12 months and is largely dependent upon the underlying malignancy.
George Antunes
openalex +5 more sources
Constrictive pericarditis presenting as chylothorax [PDF]
, 2011 Chylothorax is a rare clinical condition that can be attributed to a damaged thoracic duct. The condition is suggested by aspiration of milky white fluid from the pleural cavity and is commonly associated with either malignant diseases or trauma (e.g ...
Fatimi, Saulat H. +4 more
core
TNF-alpha, TGF-beta, and fibrinolytic parameters in tuberculous and malignant pleural effusions [PDF]
, 2000 Tae Sun Shim +11 more
openalex +1 more source
Malignant Pleural Effusion in Non-small Cell Lung Cancer—Time for a Stage Revision? [PDF]
, 2001 Frank E. Mott +2 more
openalex +1 more source
Chinese Journal of Lung Cancer, 2010 Background and objective Telomerase and CYFRA21-1 may be positively expressed in malignant pleural effusion, but the sensitivity and specificity of single tumor marker were low.
Hongmei LI +3 more
doaj
Neutrophil chemotactic factors induced by OK-432 in the treatment of malignant pleural effusion
, 1994 Ryouji Morishita
openalex +2 more sources
A Case of Malignant Pleural Effusion Treated by Chemical Pleurodesis in Ovarian Carcinoma [PDF]
, 2001 Sang Hun Han +9 more
openalex +1 more source
Pleurodesis for the Therapy of Malignant Pleural Effusions [PDF]
, 2003 Philippe Astoul
openalex +2 more sources